Cold Relief Syrup Kids Cherry

For the treatment of acute respiratory infections, such as bronchitis or the common cold, the standard adult dosage for Pelargonium Sidoides Root (standardized extract EPs 7630) is as follows:

• Oral Liquid Drops: The typical dose is 30 drops taken three times daily (morning, midday, and evening). This equates to approximately 4.5 ml to 6 ml of the liquid extract per day, depending on the concentration of the specific brand.
• Film-Coated Tablets: The standard dose is one 20 mg tablet taken three times daily.

Treatment should generally continue for 7 to 10 days. Even if symptoms improve rapidly, it is often recommended to continue taking the medication for 2 to 3 days after symptoms have subsided to prevent a relapse of the infection. Do not exceed 14 days of continuous use without consulting a healthcare professional.

Pelargonium Sidoides Root has been studied in pediatric populations, but dosage must be strictly adjusted based on age. Parents should always consult a pediatrician before administering this herbal product to children.

• Children ages 6 to 12: The typical dose is 20 drops of the liquid extract three times daily, or one 20 mg tablet twice daily (morning and evening).
• Children ages 1 to 5: The typical dose is 10 drops of the liquid extract three times daily.
• Infants under 1 year: Pelargonium Sidoides Root is generally not recommended for infants under the age of 1 due to a lack of safety data and the risk of choking or aspiration with liquid formulations.

Renal Impairment

There are no specific dose adjustment guidelines for patients with mild to moderate renal impairment. However, because metabolites are excreted renally, patients with severe kidney disease (Stage 4 or 5) should use this product with extreme caution and only under direct medical supervision.

Hepatic Impairment

Pelargonium Sidoides Root is not recommended for patients with severe liver disease. There have been rare reports of hepatotoxicity (liver injury) associated with the use of this extract. Patients with a history of hepatitis or cirrhosis should discuss alternative treatments with their doctor.

Elderly Patients

No specific dosage adjustments are required for geriatric patients unless they have underlying significant renal or hepatic dysfunction. However, healthcare providers should monitor for potential interactions with other medications the patient may be taking for chronic conditions.

To ensure maximum efficacy and safety, follow these administration guidelines:

• Administration: Liquid drops should be taken with a small amount of water or juice. Tablets should be swallowed whole with a full glass of water. Do not crush or chew film-coated tablets as this may affect the absorption rate.
• Timing: Take the doses at roughly the same time each day (e.g., 8 AM, 2 PM, and 8 PM) to maintain consistent levels in the bloodstream.
• Food: Pelargonium Sidoides Root can be taken with or without food. If you experience stomach upset, taking it with a meal may help mitigate gastrointestinal side effects.
• Storage: Store the product at room temperature (15°C to 30°C or 59°F to 86°F). Keep the bottle tightly closed and away from direct sunlight. Liquid extracts may develop a slight cloudiness over time; this is normal for herbal products and does not usually indicate spoilage.

If you miss a dose of Pelargonium Sidoides Root, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal side effects.

Symptoms of an overdose may include severe stomach pain, nausea, vomiting, or diarrhea. In rare cases, an overdose might exacerbate the risk of bleeding or liver enzyme elevation. If you suspect an overdose, contact your local poison control center or seek emergency medical attention immediately. Bring the product packaging with you to the emergency room.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop the medication prematurely without medical guidance, as this may lead to incomplete resolution of your infection.

Pelargonium Sidoides Root is generally well-tolerated, but like all medicinal substances, it can cause side effects. The most frequently reported adverse reactions involve the gastrointestinal system. These symptoms are usually mild and transient.

• Stomach Pain and Cramping: Some patients report a dull ache or cramping sensation in the upper abdomen shortly after taking the dose. This is often due to the high tannin content of the root.
• Nausea: A feeling of queasiness or the urge to vomit may occur. This is more common when the supplement is taken on an empty stomach.
• Diarrhea: Loose stools may occur as the body adjusts to the herbal extract. This typically resolves within 24 to 48 hours of starting treatment.
• Heartburn (Dyspepsia): A burning sensation in the chest or throat may occur, particularly in patients with a history of acid reflux.

These side effects occur in a smaller percentage of the population and may require monitoring:

• Mild Bleeding Gums: Some patients have reported slight bleeding from the gums when brushing their teeth. While Pelargonium coumarins are not potent anticoagulants, they may have a mild antiplatelet effect in sensitive individuals.
• Nosebleeds (Epistaxis): Occasional minor nosebleeds have been reported.
• Skin Rash: A mild, itchy red rash (urticaria) may develop in patients with sensitive skin or mild allergies to the Geraniaceae plant family.

Rare side effects are infrequent but can be more significant:

• Liver Enzyme Elevation: In very rare cases, blood tests may show an increase in transaminases (ALT, AST) or bilirubin. This indicates stress on the liver.
• Hypersensitivity Reactions: Some individuals may experience swelling of the face, lips, or tongue, which requires immediate cessation of the drug.

> Warning: Stop taking Pelargonium Sidoides Root and call your doctor immediately if you experience any of these serious symptoms.

1. 1Hepatotoxicity (Liver Damage): Signs include yellowing of the skin or eyes (jaundice), dark-colored urine, extreme fatigue, or severe pain in the upper right side of the abdomen. This is an extremely rare but serious complication.
2. 2Anaphylaxis: Symptoms include difficulty breathing, wheezing, a rapid or weak pulse, and a sudden drop in blood pressure. This is a medical emergency.
3. 3Severe Bleeding: Any unexplained bruising, blood in the stool (black, tarry stools), or coughing up blood should be reported immediately.
4. 4Severe Skin Reactions: Blistering or peeling of the skin, which could indicate a severe allergic response like Stevens-Johnson Syndrome (though this has not been definitively linked to Pelargonium, any severe rash is a concern).

Pelargonium Sidoides Root is intended for short-term use (usually 7 to 14 days). There is limited clinical data regarding the safety of using this extract for several months or years. Long-term use may theoretically lead to:

• Chronic Liver Stress: Persistent elevation of liver enzymes.
• Nutritional Deficiencies: The high tannin content could theoretically interfere with the absorption of certain minerals like iron if taken continuously for long periods.
• Immune System Alterations: Since the drug is an immunostimulant, chronic use could potentially interfere with the natural balance of the immune system.

No FDA black box warnings currently exist for Pelargonium Sidoides Root, as it is not an FDA-approved prescription drug. However, regulatory agencies in Europe (such as the BfArM in Germany) have mandated that product labels include warnings about potential liver injury and the need to monitor for symptoms of hepatotoxicity.

Report any unusual symptoms or persistent side effects to your healthcare provider. Your doctor may perform blood tests to monitor your liver function if you have been taking this product and develop unexplained fatigue or abdominal pain.

Before starting Pelargonium Sidoides Root, patients must be aware that while it is a 'natural' product, it possesses potent pharmacological activity. It should be treated with the same caution as any conventional medication. Patients with a history of autoimmune diseases, liver disorders, or coagulation (bleeding) problems must consult a physician before use. This product is not intended to treat chronic lung conditions like asthma or COPD, and it should not be used as a primary treatment for severe bacterial pneumonia which requires antibiotic therapy.

There are no FDA black box warnings for Pelargonium Sidoides Root. In the United States, it is sold as a dietary supplement or homeopathic remedy. However, healthcare providers should be aware that international regulatory bodies have issued safety communications regarding rare but serious liver injuries associated with various Pelargonium extracts.

• Hepatotoxicity Risk: There have been spontaneous reports of liver injury ranging from mild enzyme elevations to rare cases of liver failure. Patients should be screened for pre-existing liver disease before starting therapy. If signs of liver dysfunction occur, the product must be discontinued immediately.
• Allergic Reactions / Anaphylaxis: Individuals with a known allergy to members of the Geraniaceae family (geraniums) are at a higher risk of cross-reactivity. Anaphylactic reactions, though rare, have been documented.
• Bleeding Risk: Although the coumarins in Pelargonium (such as umckalin) do not typically interfere with Vitamin K-dependent clotting factors like warfarin does, they may still increase the risk of bleeding in patients already taking anticoagulants or those with bleeding disorders (e.g., hemophilia).
• Autoimmune Conditions: Because Pelargonium Sidoides Root stimulates the immune system (specifically macrophage activity and cytokine production), it could theoretically exacerbate symptoms in patients with autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), or multiple sclerosis (MS).

For the typical short-term course (7-10 days), routine lab monitoring is generally not required for healthy individuals. However, the following may be necessary for certain patients:

• Liver Function Tests (LFTs): If a patient develops jaundice, dark urine, or upper abdominal pain, LFTs (ALT, AST, Bilirubin, Alkaline Phosphatase) should be checked immediately.
• Coagulation Profiles: Patients on concurrent warfarin or heparin therapy may require more frequent INR or aPTT monitoring if their doctor approves the use of Pelargonium.

Pelargonium Sidoides Root is not known to cause sedation, dizziness, or cognitive impairment. It is generally considered safe to drive or operate heavy machinery while taking this medication. However, if you experience rare side effects like dizziness or blurred vision, avoid these activities until you know how the drug affects you.

There is no known direct interaction between Pelargonium Sidoides Root and alcohol. However, many liquid extracts of Pelargonium contain a small percentage of ethanol (alcohol) as a preservative or solvent. Patients with a history of alcohol use disorder or those taking disulfiram (Antabuse) should opt for the tablet form rather than the liquid drops. Furthermore, alcohol can irritate the stomach lining, potentially worsening the gastrointestinal side effects of the root extract.

There is no evidence of a withdrawal syndrome or a need for tapering when stopping Pelargonium Sidoides Root. It can be discontinued abruptly once the course of treatment is finished. If symptoms return after discontinuation, consult your healthcare provider to rule out a secondary bacterial infection.

> Important: Discuss all your medical conditions, especially liver health and bleeding history, with your healthcare provider before starting Pelargonium Sidoides Root.

While there are no absolute contraindications listed by the FDA, clinical pharmacology suggests that Pelargonium Sidoides Root should NEVER be used in combination with:

• Potent Immunosuppressants: Drugs like cyclosporine, tacrolimus, or high-dose systemic corticosteroids (prednisone) may have their efficacy reduced because Pelargonium acts as an immunostimulant. This could lead to organ transplant rejection or flares of autoimmune disease.

• Anticoagulants (Blood Thinners): Medications such as Warfarin (Coumadin), Rivaroxaban (Xarelto), and Apixaban (Eliquis) may have their effects potentiated. Although the coumarins in Pelargonium are structurally different from dicumarol, the theoretical risk of increased bleeding remains. Close monitoring of INR is essential.
• Antiplatelet Drugs: Aspirin, Clopidogrel (Plavix), and Ticagrelor (Brilinta) may interact with the mild anti-adhesive and antiplatelet properties of Pelargonium, potentially increasing the risk of bruising or gastrointestinal bleeding.

• NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Taking Pelargonium with Ibuprofen (Advil, Motrin) or Naproxen (Aleve) may increase the risk of stomach irritation and GI bleeding, as both substances can affect the gastric mucosa.
• Hepatotoxic Drugs: If you are taking other medications known to stress the liver (e.g., high-dose Acetaminophen, Methotrexate, or certain anti-fungals), the risk of liver enzyme elevation may be additive.

• High-Tannin Foods: Consuming Pelargonium with other high-tannin substances like tea, coffee, or red wine may increase the likelihood of stomach upset and decrease the absorption of dietary iron.
• Dairy: There is no significant evidence that dairy affects Pelargonium, but taking it with a small amount of food (including dairy) may reduce nausea.
• Alcohol: As mentioned previously, alcohol may exacerbate the risk of GI irritation and should be used sparingly during acute infections.

• Garlic, Ginkgo Biloba, and Vitamin E: These supplements have mild blood-thinning properties. Combining them with Pelargonium may further increase the risk of minor bleeding episodes.
• Echinacea and Goldenseal: These are also immunostimulants. Combining them with Pelargonium may lead to over-stimulation of the immune system, though the clinical significance of this is not well-established.
• St. John's Wort: While no direct interaction is documented, St. John's Wort induces many CYP450 enzymes. It is unknown if this significantly reduces the levels of Pelargonium's active constituents.

• Liver Function Tests: Pelargonium may cause false elevations in ALT or AST in sensitive individuals.
• Coagulation Tests (PT/INR): In rare cases, it may slightly alter INR results, particularly in patients already on anticoagulation therapy.
• Fecal Occult Blood Test: Because of the potential for minor GI irritation, a false positive for blood in the stool could theoretically occur.

Mechanism of Interactions

The primary mechanism for drug interactions with Pelargonium Sidoides Root is pharmacodynamic (additive effects on the immune system or blood clotting) rather than pharmacokinetic (interference with liver enzymes like CYP3A4). While some in vitro studies suggest Pelargonium does not significantly inhibit major CYP enzymes, clinical caution is still advised when polypharmacy is involved.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list helps prevent dangerous interactions.

Pelargonium Sidoides Root must NEVER be used in the following circumstances:

1. 1Severe Liver Disease: This includes active hepatitis, cirrhosis, or any condition where liver function is significantly compromised. Because of the rare reports of hepatotoxicity, the risk in these patients far outweighs any potential benefit for a respiratory infection.
2. 2Known Hypersensitivity: Anyone who has had a previous allergic reaction (rash, hives, swelling, or difficulty breathing) to Pelargonium Sidoides or any member of the Geraniaceae family must avoid this product.
3. 3Severe Renal Disease: Patients on dialysis or with a GFR below 15 mL/min should avoid use due to the lack of safety data regarding the clearance of metabolites.
4. 4Active Internal Bleeding: Patients with active peptic ulcers or recent intracranial hemorrhage should not use Pelargonium due to the theoretical risk of prolonged bleeding.

In these situations, a healthcare provider must perform a careful risk-benefit analysis:

• Autoimmune Disorders: Patients with Lupus, RA, or Crohn's disease should be cautious, as the immunostimulatory effects of the root could trigger a flare-up of their condition.
• Pregnancy and Lactation: Due to the absence of high-quality clinical trials in pregnant or nursing women, use is generally discouraged unless specifically directed by a physician.
• Pre-operative Patients: It is generally recommended to stop taking Pelargonium at least 2 weeks before scheduled surgery to minimize any risk of increased bleeding during the procedure.

Patients who are allergic to other species of geranium or related plants in the Geraniaceae family may experience cross-sensitivity. Symptoms of cross-sensitivity can range from mild contact dermatitis (skin rash) to systemic allergic reactions. If you have a known botanical allergy, discuss this with an allergist before using Pelargonium Sidoides Root.

> Important: Your healthcare provider will evaluate your complete medical history, including your liver enzymes and medication list, before determining if Pelargonium Sidoides Root is safe for you.

Pelargonium Sidoides Root is currently classified as Category C (or equivalent in herbal medicine). This means that there are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been extensively performed for the standardized extract EPs 7630.

• First Trimester: Avoid use, as this is the critical period for organogenesis (organ formation).
• Second and Third Trimesters: Use is only recommended if the potential benefit justifies the potential risk to the fetus. There is a theoretical concern regarding the coumarin content, although these are not the same as the teratogenic coumarins found in certain rodenticides.
• Fertility: There is no evidence suggesting that Pelargonium Sidoides Root affects male or female fertility.

It is unknown whether the active constituents of Pelargonium Sidoides Root are excreted into human breast milk. Because many of the polyphenols and coumarins have low molecular weights, some transfer is likely. Due to the lack of safety data for nursing infants, the use of this product while breastfeeding is generally not recommended. If treatment is necessary, a healthcare provider may suggest temporarily pumping and discarding milk or using an alternative therapy with a more established safety profile.

Pelargonium Sidoides Root has been studied in children as young as 1 year old for the treatment of acute bronchitis and tonsillopharyngitis.

• Approved Use: It is often used in Europe for children over 6 years old.
• Caution: For children between 1 and 6 years, it should only be administered under the strict supervision of a pediatrician.
• Growth Effects: There are no reports of the extract affecting growth or development in children when used for short-term courses.
• Risk: The primary risk in children is gastrointestinal upset and the potential for allergic reactions.

Clinical trials have included patients over the age of 65, and no specific age-related adverse effects have been identified. However, the elderly are more likely to have:

• Reduced Renal Clearance: This may lead to higher systemic levels of the extract's metabolites.
• Polypharmacy: The risk of drug-drug interactions (especially with anticoagulants for atrial fibrillation or heart disease) is much higher in this population.
• Fall Risk: While the drug doesn't cause dizziness, the gastrointestinal effects (dehydration from diarrhea) could indirectly increase fall risk in frail patients.

There is a lack of specific data for patients with kidney disease. Since the kidneys are a primary route of elimination for the metabolites of umckalin and gallic acid, patients with a GFR < 30 mL/min should be monitored closely. No specific dose reduction has been validated, but a lower frequency of dosing (e.g., twice daily instead of three times) may be considered by a physician.

Pelargonium Sidoides Root is contraindicated in patients with significant hepatic impairment. The liver is responsible for metabolizing the coumarin and phenolic components of the extract. In patients with Child-Pugh Class B or C cirrhosis, the risk of further liver injury or altered drug metabolism is too high to recommend use.

> Important: Special populations require individualized medical assessment. Never give herbal supplements to children or pregnant women without professional medical advice.

Pelargonium Sidoides Root (EPs 7630) functions through a complex interplay of immunomodulatory, antiviral, and antibacterial mechanisms.

1. 1Immunomodulation: The extract stimulates the non-specific immune system. It increases the production of nitric oxide (NO) in macrophages, which is a potent killer of intracellular pathogens. It also induces the release of cytokines like IFN-β, which increases the antiviral resistance of surrounding cells.
2. 2Antiviral Effects: In vitro studies show that Pelargonium prevents the replication of several respiratory viruses, including seasonal influenza A (H1N1, H3N2), respiratory syncytial virus (RSV), and human coronavirus. It does this by inhibiting the viral entry into host cells and interfering with the neuraminidase enzyme (similar to, but weaker than, oseltamivir).
3. 3Antibacterial Activity: While not a direct antibiotic, it prevents bacteria from adhering to the mucous membrane cells of the respiratory tract, making it easier for the body to flush them out.

The onset of action for symptomatic relief is typically within 48 to 72 hours of starting the medication. The duration of effect lasts for approximately 6 to 8 hours, which is why three-times-daily dosing is required. There is no evidence of tolerance development with short-term use (up to 14 days).

| Parameter | Value |

|---|---|

| Bioavailability | Estimated 30-50% (polyphenols) |

| Protein Binding | Moderate (approx. 40-60%) |

| Half-life | 2 - 4 hours (marker compounds) |

| Tmax | 1.5 - 3 hours |

| Metabolism | Hepatic (Phase I and II) |

| Excretion | Renal (primary), Fecal (secondary) |

• Active Constituents: The extract contains oxygenated coumarins (umckalin, 5,6,7-trimethoxycoumarin), gallic acids, and highly polymerized oligomeric prodelphinidins.
• Molecular Formula: Umckalin (C12H12O6) is the primary marker.
• Molecular Weight: 252.22 g/mol (Umckalin).
• Solubility: The extract is soluble in ethanol/water mixtures, which is why liquid drops are a common formulation.

Pelargonium Sidoides Root is classified as a Phytotherapeutic Respiratory Agent. It is often grouped with other herbal expectorants and immunomodulators like Echinacea purpurea or Ivy leaf extract (Hedera helix), though its specific mechanism in bronchitis is unique among these agents.